The number of new drugs approved every year by the Food and Drug Administration has remained constant, even as scientists have learned a great deal more about biology. Figuring out why better science hasn’t meant more drugs is one of the great puzzles facing the global pharmaceuticals industry. (See this spirited discussion of the obstacles facing drug companies, which has been going like mad for days now.)
Most people who follow the drug industry are pretty familiar with the following graph, which shows the number of new medicines, or new molecular entities, going back to 1940.
That’s already pretty bad, because despite all the increased resources that have been put into new drug research, we’re pretty close to a low point in terms of the number of new drugs approved. But what if we take a look at the number of new drugs approved per billion dollars spent? Analysts at Sanford C. Bernstein did that, and their chart was included in a wonderful report on R&D outsourcing to India put together by the Boston Consulting Group.
Click sobre imagen para ampliar
Entradas
No hay comentarios:
Publicar un comentario